Transparency Reporting. Each Party shall be responsible for tracking and reporting transfers of value initiated and controlled by its and its Affiliates’ employees, contractors, and agents pursuant to the requirements of the marketing reporting laws of any Government Authority in the Territory, including Section 6002 of the Patient Protection and Affordable Care Act, commonly referred to as the “Sunshine Act.”
Appears in 5 contracts
Sources: License Agreement (Phathom Pharmaceuticals, Inc.), License Agreement (Phathom Pharmaceuticals, Inc.), License Agreement (Rhythm Pharmaceuticals, Inc.)
Transparency Reporting. Each Party shall be responsible for tracking and reporting transfers of value initiated and controlled by its and its Affiliates’ employees, independent contractors, and agents pursuant to the requirements of the marketing reporting laws of any Government Authority in the Territory, including Section 6002 of the Patient Protection and Affordable Care Act, commonly referred to as the “Sunshine Act.”
Appears in 4 contracts
Sources: Common Stock Purchase Agreement (Ultragenyx Pharmaceutical Inc.), License and Collaboration Agreement (Ultragenyx Pharmaceutical Inc.), License and Collaboration Agreement (Ultragenyx Pharmaceutical Inc.)
Transparency Reporting. Each Party shall will be responsible for tracking and reporting transfers of value initiated and controlled by its and its Affiliates’ employees, contractors, and agents pursuant to the requirements of the marketing reporting laws of any Government Authority in the Licensee Territory, including Section 6002 of the Patient Protection and Affordable Care Act, commonly referred to as the “Sunshine Act.”
Appears in 4 contracts
Sources: License Agreement (Myovant Sciences Ltd.), License Agreement (Myovant Sciences Ltd.), License Agreement (Myovant Sciences Ltd.)
Transparency Reporting. Each Party shall be responsible for tracking and reporting transfers of value initiated and controlled by its and its Affiliates’ employees, contractors, and agents pursuant to the requirements of the marketing reporting laws of any Government Authority in the TerritoryAuthority, including Section 6002 of the Patient Protection and Affordable Care Act, commonly referred to as the “Sunshine Act.”
Appears in 2 contracts
Sources: License Agreement (HilleVax, Inc.), License Agreement (HilleVax, Inc.)
Transparency Reporting. Each Party shall be responsible for tracking and reporting transfers of value initiated and controlled by its and or on behalf of such Party’s or its Affiliates’ employees, contractors, and agents pursuant to the requirements of the marketing reporting laws of any Government Governmental Authority in the Territory, including Section 6002 of the Patient Protection and Affordable Care ActACA, commonly referred to as the “Sunshine Act.”
Appears in 2 contracts
Sources: Global Collaboration and License Agreement (Macrogenics Inc), Global Collaboration and License Agreement (Incyte Corp)
Transparency Reporting. Each Party shall be responsible for tracking and reporting transfers of value initiated and controlled by its and its Affiliates’ employees, contractors, contractors and agents pursuant to the requirements of the marketing reporting laws of any Government Governmental Authority in the Territory, including Section 6002 of the Patient Protection and Affordable Care Act, commonly referred to as the “Sunshine Act.”
Appears in 1 contract
Sources: Research and Development Collaboration and License Agreement (Compass Therapeutics, Inc.)
Transparency Reporting. Each Party shall be responsible for tracking and reporting transfers of value initiated and controlled by its and its Affiliates’ employees, contractors, and agents pursuant to the requirements of the marketing reporting transparency laws of any Government Governmental Authority in the Territory, including Section 6002 of the Patient Protection and Affordable Care ActACA, commonly referred to as the “Sunshine Act.”
Appears in 1 contract
Sources: Strategic Collaboration and License Agreement (Codexis, Inc.)
Transparency Reporting. Each Party shall will be responsible for tracking and reporting transfers of value initiated and controlled by its and its Affiliates’ employees, contractors, and agents pursuant to the requirements of the marketing reporting laws of any Government Governmental Authority in the Territory, including Section 6002 of the Patient Protection and Affordable Care Act, commonly referred to as the “Sunshine Act.”
Appears in 1 contract
Sources: Asset Transfer and License Agreement (Day One Biopharmaceuticals Holding Co LLC)
Transparency Reporting. Each Party shall will be responsible for tracking and reporting transfers of value initiated and controlled by its and its Affiliates’ employees, contractors, and agents pursuant to the requirements of the transparency or marketing reporting laws of any Government Governmental Authority in the Territory, including Section 6002 of the Patient Protection and Affordable Care ActACA, commonly referred to as the “Sunshine Act.”
Appears in 1 contract
Sources: Exclusive Research Collaboration, License and Option Agreement (LogicBio Therapeutics, Inc.)
Transparency Reporting. Each Party shall be responsible for tracking and reporting transfers of value initiated and controlled by its and its Affiliates’ employees, contractors, and agents pursuant to the requirements of the transparency or marketing reporting laws of any Government Governmental Authority in the Territory, including Section 6002 of the Patient Protection and Affordable Care ActACA, commonly referred to as the “Sunshine Act.”
Appears in 1 contract
Sources: Research Collaboration and Co Development Agreement (NextCure, Inc.)
Transparency Reporting. Each Party shall be responsible for tracking and reporting transfers of value initiated and controlled by its and its Affiliates’ employees, contractors, and agents pursuant to the requirements of the marketing reporting transparency laws of any Government Governmental Authority in the Territory, including Section 6002 of the Patient Protection and Affordable Care Act, Pub. L. No. 111-148, as amended, commonly referred to as the “Sunshine Act.”
Appears in 1 contract
Sources: Commercialization and License Agreement (CytoDyn Inc.)